4//SEC Filing
Easom Eric 4
Accession 0001610717-24-000164
CIK 0001880438other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 7:26 PM ET
Size
29.5 KB
Accession
0001610717-24-000164
Insider Transaction Report
Form 4
Easom Eric
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2024-03-15+99,000→ 101,130 total - Award
Stock Option (right to buy)
2024-03-15+198,000→ 198,000 totalExercise: $3.00Exp: 2034-03-14→ Common Stock (198,000 underlying)
Holdings
- 97,058(indirect: See Footnote)
Common Stock
- 97,058(indirect: See Footnote)
Common Stock
- 1,015,766(indirect: See Footnote)
Common Stock
Footnotes (5)
- [F1]These restricted stock units vest as follows: 1/16th of the shares vests quarterly over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.
- [F2]Consists of shares of Common Stock held by the Easom Living Trust dated August 21, 2019.
- [F3]Consists of shares of Common Stock held by the C Easom Irrevocable Trust dated October 8, 2021.
- [F4]Consists of shares of Common Stock held by the Jude Easom Irrevocable Trust dated October 8, 2021.
- [F5]The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001914503
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 7:26 PM ET
- Size
- 29.5 KB